DE69224058T2 - Benzodioxanderivate - Google Patents

Benzodioxanderivate

Info

Publication number
DE69224058T2
DE69224058T2 DE69224058T DE69224058T DE69224058T2 DE 69224058 T2 DE69224058 T2 DE 69224058T2 DE 69224058 T DE69224058 T DE 69224058T DE 69224058 T DE69224058 T DE 69224058T DE 69224058 T2 DE69224058 T2 DE 69224058T2
Authority
DE
Germany
Prior art keywords
compound
group
give
methylene chloride
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69224058T
Other languages
German (de)
English (en)
Other versions
DE69224058D1 (de
Inventor
Hirokazu Chugai Seiyaku Kabushiki Kaisha Gotenba-Shi Shizuoka 412 Hamada
Yoshitake Chugai Seiyaku Kabushiki Kaisha Gotenba-Shi Shizuoka 412 Kanbe
Akira Chugai Seiyaku Kabushiki Kaisha Gotenba-Shi Shizuoka 412 Koda
Tatsuo Chugai Seiyaku Kabushiki Kaisha Gotenba-Shi Shizuoka 412 Miyauchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE69224058D1 publication Critical patent/DE69224058D1/de
Application granted granted Critical
Publication of DE69224058T2 publication Critical patent/DE69224058T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69224058T 1991-10-22 1992-10-21 Benzodioxanderivate Expired - Fee Related DE69224058T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP27403691 1991-10-22
JP10757092 1992-04-27
JP04278776A JP3136206B2 (ja) 1991-10-22 1992-10-16 ベンゾジオキサン誘導体
PCT/JP1992/001366 WO1993008182A1 (fr) 1991-10-22 1992-10-21 Derive de benzodioxane

Publications (2)

Publication Number Publication Date
DE69224058D1 DE69224058D1 (de) 1998-02-19
DE69224058T2 true DE69224058T2 (de) 1998-10-15

Family

ID=27311013

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69224058T Expired - Fee Related DE69224058T2 (de) 1991-10-22 1992-10-21 Benzodioxanderivate

Country Status (12)

Country Link
US (1) US5480905A (enExample)
EP (1) EP0565732B1 (enExample)
JP (1) JP3136206B2 (enExample)
KR (1) KR100217166B1 (enExample)
AT (1) ATE162189T1 (enExample)
AU (1) AU2798692A (enExample)
CA (1) CA2098821C (enExample)
DE (1) DE69224058T2 (enExample)
ES (1) ES2112337T3 (enExample)
SG (1) SG50640A1 (enExample)
TW (1) TW206222B (enExample)
WO (1) WO1993008182A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3235448B2 (ja) * 1995-03-24 2001-12-04 ダイソー株式会社 １，４−ベンゾジオキサン誘導体の製法
DK0870757T3 (da) * 1997-04-10 2002-07-15 Pfizer Fluorsubstituerede adamantanderivater
WO1998051680A1 (en) * 1997-05-12 1998-11-19 Daiso Co., Ltd. Process for producing 1,4-benzodioxane derivatives
JP4604583B2 (ja) * 2004-07-20 2011-01-05 ダイソー株式会社 １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法
US8552078B2 (en) * 2006-10-17 2013-10-08 Air Products And Chemicals, Inc. Crosslinkers for improving stability of polyurethane foams
WO2008118935A1 (en) * 2007-03-26 2008-10-02 Neurogen Corporation Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-ones
GB201801130D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1244418A (en) * 1984-07-30 1988-11-08 Marcel Hibert Glutarimide antianxiety and antihypertensive agents
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
US5010078A (en) * 1988-05-24 1991-04-23 American Home Products Corporation Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity
US5036070A (en) * 1990-06-13 1991-07-30 American Home Products Corporation Polycyclic phenalkyl amines as psychotropic agents
US5126367A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Psychotropic benzodioxan derivatives

Also Published As

Publication number Publication date
AU2798692A (en) 1993-05-21
US5480905A (en) 1996-01-02
ES2112337T3 (es) 1998-04-01
TW206222B (enExample) 1993-05-21
DE69224058D1 (de) 1998-02-19
EP0565732A4 (enExample) 1994-04-27
JPH069613A (ja) 1994-01-18
EP0565732A1 (en) 1993-10-20
JP3136206B2 (ja) 2001-02-19
EP0565732B1 (en) 1998-01-14
CA2098821C (en) 2004-01-27
CA2098821A1 (en) 1993-04-23
SG50640A1 (en) 1998-07-20
WO1993008182A1 (fr) 1993-04-29
ATE162189T1 (de) 1998-01-15
KR100217166B1 (ko) 1999-09-01

Similar Documents

Publication Publication Date Title
DE69323630T2 (de) Benzokondensierte verbindungen
DE69128236T2 (de) N-Acyl-2,3-benzodiazepin-Derivate, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung
DE60103927T2 (de) Piperazinderivate, deren Herstellung und deren Verwendung in der Behandlung von Störungen des Zentralnervensystems
DE69200685T2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten.
EP0031080B1 (de) 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2125634A1 (de) Verfahren zur Herstellung von neuen Cycloheptenderivaten
DE2363052A1 (de) 3-phenyl-3-aminoalkyl-2,6-dioxo-tetraund -hexahydropyridine, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zubereitungen
DE69720021T2 (de) 1,4-disubstituierte piperazine
DE69224058T2 (de) Benzodioxanderivate
DE69720715T2 (de) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
DE3856501T2 (de) Schlafverbesserungsmittel
DE69102477T2 (de) 3-Aminochroman-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DD272648A5 (de) Chromon-derivate
DE69810560T2 (de) Indanol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69130266T2 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
DE3309655A1 (de) 1,2,5-thiadiazol-1-oxide und 1,1-dioxide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0254955A2 (de) Substituierte Pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69115954T2 (de) Kondensierte 7-gliedrige zyklische Verbindungen und diese enthaltende antipsychotische Zubereitung
DE602005006018T2 (de) Arylpiperazinderivate und deren verwendung als für den dopamin-d3-rezeptor selektive liganden
WO1982002891A1 (en) Amino-2,1,3-benzothiadiazol and benzoxadiazol derivatives,preparation thereof and drugs containing them
DE69300197T2 (de) Aminoalkylchromone, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen.
DE3630539A1 (de) Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten
DE69024385T2 (de) Verbindung zur Behandlung von Störungen des Neurotransmittersystems im Gehirn
DE2412520A1 (de) Tricyclische verbindungen
DE69405999T2 (de) Pharmazeutisch wirksame enantiomere

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee